Wednesday, 27 April 2016

Cardiac Rhythm Management Devices Market Parameters 2007-2021 United Kingdom

Summary

GlobalData’s new report, "United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United Kingdom Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.



Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the United Kingdom Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.


Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents 

1 Table of Contents 2
    1.1 List of Tables 4
    1.2 List of Figures 5
2 Introduction 6
    2.1 What Is This Report About? 6
    2.2 Cardiac Rhythm Management Devices Market Segmentation 6
    2.3 Definitions of Markets Covered in the Report 7 

Make an enquiry before buying this Report @

3 Cardiac Rhythm Management Devices Market, United Kingdom 9
    3.1 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2007-2014 9
    3.2 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2014-2021 11
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 19
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 21
      3.2.6 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 23
    3.3 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2007-2014 25
    3.4 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2014-2021 27
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2007-2014 29
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2007-2014 31
      3.4.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2007-2014 33
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2014-2021 35
      3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2014-2021 37
      3.4.6 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2014-2021 39
    3.5 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2007-2021 41
    3.6 Cardiac Rhythm Management Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 43
    3.7 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2014 44 


4 Overview of Key Companies in United Kingdom, Cardiac Rhythm Management Devices Market 46 
    4.1 Medtronic plc 46
      4.1.1 Company Overview 46
    4.2 St. Jude Medical, Inc. 46
      4.2.1 Company Overview 46
    4.3 Boston Scientific Corporation 46
      4.3.1 Company Overview 46
    4.4 Biotronik SE & Co. KG 47
      4.4.1 Company Overview 47
    4.5 Sorin S.p.A. (Inactive) 47
      4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Financial Deals Landscape 49

    6.1 Acquisition 49
      6.1.1 Mittel Plans to Sell 6% Interest in LivaNova 49
7 Recent Developments 50
    7.1 Financial Announcements 50
      7.1.1 Nov 12, 2015: LivaNova Provides Business Update 50
    7.2 Legal And Regulatory 52
      7.2.1 Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter 52
8 Appendix 54
    8.1 Research Methodology 55
      8.1.1 Coverage 55
      8.1.2 Secondary Research 55
      8.1.3 Primary Research 56
      8.1.4 Market Modeling and Forecasting 57
      8.1.5 Company Share Analysis 60
      8.1.6 Distribution Share Analysis 61
    8.2 Expert Panel 62
    8.3 GlobalData Consulting 62
    8.4 Contact Us 62
    8.5 Disclaimer 62


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

No comments:

Post a Comment